AVEO制药

AVEO NASDAQ
0.6824
-0.0276
-3.89%
交易中 10:28 07/22 EDT
开盘
0.7000
昨收
0.7100
最高
0.7069
最低
0.6800
成交量
94.74万
成交均量(3M)
260.01万
52周最高
3.590
52周最低
0.4906
换手率
0.59%
市值
1.10亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供AVEO制药 AVEO股票价格,AVEO制药股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company. The Company's platform delivers insights into cancer and related disease. The Company's product candidates include Tivozanib, Ficlatuzumab, AV-203 and AV-380. Tivozanib is a selective long half-life vascular endothelial growth factor tyrosine kinase inhibitor (VEGF TKI) that inhibits over three VEGF receptors. Tivozanib is designed to optimize VEGF blockade while minimizing off-target toxicities. Ficlatuzumab is a Hepatocyte Growth Factor (HGF) inhibitory antibody. AV-203 is an anti-ErbB3 monoclonal antibody with ErbB3 affinity. Its preclinical studies suggest that neuregulin1 (NRG1) levels predict AV-203 antitumor activity in preclinical models. AV-380 is a humanized Immunoglobulin G 1 (IgG1) inhibitory monoclonal antibody. AV-380 targets growth differentiating factor 15 (GDF15).
展开 >

最近浏览

名称
价格
涨跌幅